Ingevity Q2 net sales +15% to $481.8M; adj. EPS $1.41; FY23 guidance $1.6-$1.7B sales

Ingevity Corp

2023-Q2 EPS reported $2.33 revenue$874,400,000

Net sales $481.8M (+15% YoY); net income $35.5M ($0.97 diluted EPS); adjusted EPS $1.41.
Adjusted EBITDA $120.7M (margin 25.1%); operating cash flow $48.4M, free cash flow $26.7M.
Initiated cost reduction actions targeting ~$35M annual savings; ~$20M expected in 2023.
Adjusted 2023 guidance: sales $1.6B-$1.7B, adjusted EBITDA $390M-$420M.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Ingevity Corp reported preliminary financial results for three and six months ended June 30, 2023.

Period: three and six months ended June 30, 2023
Result: preliminary results

Exact text from the filing

On August 2, 2023, Ingevity Corporation ("Ingevity") announced its preliminary financial results for the three and six months ended June 30, 2023 which are attached as Exhibit 99.1 to this Current Report on Form 8-K.

View on SEC.gov

Browse all earnings releases →

Ingevity Corp filing history →

Source: SEC EDGAR

accession 0001653477-23-000044

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.